Anaesthesia and Intensive care – Rebecka Rubenson Wahlin/Anna Schandl's research group

Our research

The main goal of the research is to improve care, treatment and outcomes for the critically ill and/or operated patients through clinical studies. The department also holds a clinical research unit with two employed research nurses with high competence and experience in patient-centered clinical research, study monitoring and complex data collection and biobanking. The unit has a well-structured system for study monitoring and follow-up.

Research projects

More study-specific information about each project can be found on the individual researcher’s profile page

Anaesthesia/perioperative care

Fluid therapy and hemodynamics – Rebecka Rubenson Wahlin, Eva Joelsson-Alm, Christer Svensén

Airway management – Mattias Günther

Intensive care

Fluid treatment in sepsis and intensive care – Rebecka Rubenson Wahlin, Eva Joelsson-Alm

Diabetes in critically ill patients – Anca Balintescu

Long-term follow-up after critical illness –  Eva Joelsson-Alm, Anna Schandl, Gisela Vogel

Treatment of critically ill patients with Covid-19 – Rebecka Rubenson Wahlin, Mattias Günther, Eva Joelsson-Alm, Anna Schandl, Christer Svensén

Oxygen project on septic pig – Mattias Günther, Christer Svensén

Emergency care/Prehospital care

Sepsis, early detection and treatment – Rebecka Rubenson Wahlin, Eva Joelsson-Alm

Acute Assessment and Treatment of Traumatic Brain Injury – Rebecka Rubenson Wahlin

Sepsis, early detection and treatment in ambulance care – Rebecka Rubenson Wahlin

Acute assessment and treatment of TBI and geriatric trauma – Rebecka Rubenson Wahlin


Alice Kane, Harvard University/University of Washington

Eric Thelin, Karolinska Universitetssjukhuset

CRIC nätverket

Denise Bäckström, KMC, Linköping Universitet 


Selected publications

Restriction of Intravenous Fluid in ICU Patients with Septic Shock.
Meyhoff TS, Hjortrup PB, Cronhjort M, Joelsson-Alm E, et al. 
N Engl J Med 2022 Jun;386(26):2459-2470

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
Munch MW, Wahlin RR, Cronhjort M, Hollenberg J, et al.
JAMA 2021 Nov;326(18):1807-1817

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia.
Granholm A, Kjær MN, Cronhjort M, Wahlin RR, et al.
Intensive Care Med 2022 May;48(5):580-589

Development of an ICU discharge instrument predicting psychological morbidity: a multinational study.
Milton A, Schandl A, Soliman IW, et al.
Intensive Care Med 2018 Dec;44(12):2038-2047

Intensive care nurses' lived experience of altruism and sacrifices during the Covid-19 pandemic: A phenomenological study.
Slettmyr A, Arman M, Andermo S, Schandl A, et al.
J Adv Nurs 2023 Jan;79(1):244-253

Glycemic Control and Risk of Sepsis and Subsequent Mortality in Type 2 Diabetes.
Balintescu A, Lind M, Franko MA, Oldner A, Cronhjort M, et al.
Diabetes Care 2022 Jan;45(1):127-133

Stabilizing life: A grounded theory of surviving critical illness.
Vogel G, Joelsson-Alm E, Forinder U, Svensen C, Sandgren A
Intensive Crit Care Nurs 2021 Dec;67():103096

An observational study of intermediate- or high-dose thromboprophylaxis for critically ill COVID-19 patients.
Jonmarker S, Litorell J, Dahlberg M, Stackelberg O, Everhov ÅH, Söderberg M, Rubenson-Wahlin R, Günther M, Mårtensson J, Hollenberg J, Joelsson-Alm E, Cronhjort M
Acta Anaesthesiol Scand 2022 Mar;66(3):365-374

Family members' experiences of COVID-19 visiting restrictions in the intensive care unit-A qualitative study.
Forsberg T, Isaksson M, Schelin C, Lyngå P, Schandl A
J Clin Nurs 2023 Jan;():

Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
Jonmarker S, Hollenberg J, Dahlberg M, Stackelberg O, Litorell J, Everhov ÅH, Järnbert-Pettersson H, Söderberg M, Grip J, Schandl A, Günther M, Cronhjort M
Crit Care 2020 Nov;24(1):653

Staff and contact

Group leader

All members of the group